Spire Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3K Buy
363
+110
+43% +$3.5K ﹤0.01% 1522
2026
Q1
$6.68K Hold
253
﹤0.01% 1749
2025
Q4
$7.33K Hold
253
﹤0.01% 1818
2025
Q3
$7.03K Sell
253
-55
-18% -$1.39K ﹤0.01% 1877
2025
Q2
$7.5K Hold
308
﹤0.01% 1817
2025
Q1
$6.39K Hold
308
﹤0.01% 1990
2024
Q4
$7.25K Sell
308
-1
-0.3% -$25 ﹤0.01% 1937
2024
Q3
$7.91K Sell
309
-28
-8% -$713 ﹤0.01% 1704
2024
Q2
$7.92K Sell
337
-104
-24% -$2.63K ﹤0.01% 1707
2024
Q1
$12.7K Buy
441
+65
+17% +$1.96K ﹤0.01% 1642
2023
Q4
$10.8K Sell
376
-500
-57% -$13.6K ﹤0.01% 1735
2023
Q3
$24.4K Sell
876
-362
-29% -$11.8K ﹤0.01% 1428
2023
Q2
$42.2K Sell
1,238
-96
-7% -$3.02K ﹤0.01% 1265
2023
Q1
$40.1K Buy
1,334
+471
+55% +$14.6K ﹤0.01% 1288
2022
Q4
$24K Sell
863
-1,730
-67% -$54.9K ﹤0.01% 1292
2022
Q3
$85K Sell
2,593
-2,060
-44% -$75.6K 0.01% 759
2022
Q2
$147K Sell
4,653
-5,432
-54% -$190K 0.01% 874
2022
Q1
$463K Sell
10,085
-3,049
-23% -$145K 0.01% 599
2021
Q4
$804K Sell
13,134
-1,153
-8% -$79.7K 0.02% 544
2021
Q3
$1.07M Sell
14,287
-226
-2% -$19K 0.03% 396
2021
Q2
$1.34M Sell
14,513
-4,919
-25% -$418K 0.04% 357
2021
Q1
$1.7M Buy
+19,432
New +$1.93M 0.05% 319

Other funds holding ARKG

Spire Wealth Management's ARKG Position: Q2 2026 in Review

Spire Wealth Management increased its ARK Genomic Revolution ETF (ARKG) stake by 43% in Q2 2026, buying an estimated $3.5K and bringing the position to 363 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Spire Wealth Management first reported a position in ARKG in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.7M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Spire Wealth Management held 363 shares of ARK Genomic Revolution ETF worth $15.3K as of Q2 2026.
  • Spire Wealth Management bought 110 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.5K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1522 holding.
  • Spire Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's ARK Genomic Revolution ETF position peaked at $1.7M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.